Ception Raises $63 Million

Ception Therapeutics Inc., a Malvern, Pa.-based drug company whose lead candidates are anti-inflammatories, has raised $63 million in Series C funding. Essex Woodlands Health Ventures led the deal, and was joined by Investor Growth Capital, MDS Life Sciences, New Science Ventures and Aperture Venture Partners. www.ceptiontx.com